rss
Br J Ophthalmol 2008;92:584 doi:10.1136/bjo.2007.126193
  • Mailbox
    • PostScript

Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration

  1. G Mojica1,
  2. S M Hariprasad2,
  3. R D Jager2,
  4. W F Mieler2
  1. 1
    University of Chicago Pritzker School of Medicine, Chicago, IL, USA
  2. 2
    Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA
  1. S M Hariprasad, Department of Ophthalmology and Visual Science, University of Chicago, 5841 South Maryland, MC 2114, Chicago, IL 60637, USA; retina{at}uchicago.edu
  • Accepted 10 August 2007

Rosenfeld and colleagues reported that ranibizumab (Lucentis) had no long-term effect on intraocular pressure (IOP) as determined by monthly measurements during the 2-year MARINA study.1 We are unaware of previous studies examining the short-term effect on IOP by intravitreal ranibizumab in patients with wet age-related macular degeneration.

Methods

We conducted a retrospective chart review of 50 ranibizumab injections from 23 patients. IOP was recorded using Goldmann applanation tonometry. All patients included in this series received ranibizumab injection as directed by the instructions provided in the package insert (volume …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.